PATH works to ensure that diagnostic tools to improve malaria case management and contribute to elimination are available and accessible to malaria endemic populations. We collaborate with partners to develop, evaluate, and commercialize highly sensitive tests to detect low-density infections and point-of-care tests for G6PD deficiency to guide treatment of patients with Plasmodium vivax. PATH provides biological materials as well as market and technology landscaping assistance to test developers to support the development and implementation of diagnostic testing.
PATH is the convener of the G6PD Operations Research Community of Practice that brings together researchers, organizations, and clinicians committed to advancing the introduction and scale-up of G6PD diagnostics in support of safe access to radical cure treatment for Plasmodium vivax malaria through operations research.
Below are resources developed for our partners. New resources are added on a regular basis. If you do not see the resource you are looking for, please contact email@example.com.
Standard Operating Procedures: